181 related articles for article (PubMed ID: 19073002)
1. Pathology reporting in head and neck cancer--snapshot of current status.
King B; Corry J
Head Neck; 2009 Feb; 31(2):227-31; discussion 232-3. PubMed ID: 19073002
[TBL] [Abstract][Full Text] [Related]
2. Deficiencies in pathological reporting of colorectal cancer in Victoria.
Winn RD; Robinson DR; Farmer KC; Bell SW
ANZ J Surg; 2008 Sep; 78(9):796-9. PubMed ID: 18844912
[TBL] [Abstract][Full Text] [Related]
3. An audit of breast cancer pathology reporting in Australia in 1995.
Kricker A; Armstrong B; Smith C; Bilous M; Camaris C; Mayer A; Psarianos T
Br J Cancer; 1999 May; 80(3-4):563-8. PubMed ID: 10408867
[TBL] [Abstract][Full Text] [Related]
4. Pathology reporting of breast cancer: trends in 1989-1999, following the introduction of mammographic screening in Western Australia.
Harvey JM; Sterrett GF; McEvoy S; Fritschi L; Jamrozik K; Ingram D; Joseph D; Dewar J; Byrne MJ;
Pathology; 2005 Oct; 37(5):341-6. PubMed ID: 16194843
[TBL] [Abstract][Full Text] [Related]
5. Planned neck dissection following primary chemoradiation for advanced-stage head and neck cancer.
Sabatini PR; Ducic Y
Otolaryngol Head Neck Surg; 2009 Oct; 141(4):474-7. PubMed ID: 19786215
[TBL] [Abstract][Full Text] [Related]
6. Does use of alternative medicine delay treatment of head and neck cancer? A surveillance, epidemiology, and end results (SEER) cancer registry study.
Kato I; Neale AV
Head Neck; 2008 Apr; 30(4):446-54. PubMed ID: 18023030
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic risk factors for distant metastases from head and neck squamous cell carcinomas.
Li X; Di B; Shang Y; Zhou Y; Cheng J; He Z
Eur J Surg Oncol; 2009 Dec; 35(12):1348-53. PubMed ID: 19616915
[TBL] [Abstract][Full Text] [Related]
8. Feasibility and efficacy of accelerated weekly concomitant boost postoperative radiation therapy combined with concomitant chemotherapy in patients with locally advanced head and neck cancer.
Pehlivan B; Luthi F; Matzinger O; Betz M; Dragusanu D; Bulling S; Bron L; Pasche P; Seelentag W; Mirimanoff RO; Zouhair A; Ozsahin M
Ann Surg Oncol; 2009 May; 16(5):1337-43. PubMed ID: 19280263
[TBL] [Abstract][Full Text] [Related]
9. Critical evaluation of frozen section margins in head and neck cancer resections.
Black C; Marotti J; Zarovnaya E; Paydarfar J
Cancer; 2006 Dec; 107(12):2792-800. PubMed ID: 17120195
[TBL] [Abstract][Full Text] [Related]
10. The use of a proforma improves colorectal cancer pathology reporting.
Rigby K; Brown SR; Lakin G; Balsitis M; Hosie KB
Ann R Coll Surg Engl; 1999 Nov; 81(6):401-3. PubMed ID: 10655894
[TBL] [Abstract][Full Text] [Related]
11. Metastatic cutaneous squamous cell carcinoma of the head and neck: the Immunosuppression, Treatment, Extranodal spread, and Margin status (ITEM) prognostic score to predict outcome and the need to improve survival.
Oddone N; Morgan GJ; Palme CE; Perera L; Shannon J; Wong E; Gebski V; Veness MJ
Cancer; 2009 May; 115(9):1883-91. PubMed ID: 19224549
[TBL] [Abstract][Full Text] [Related]
12. Prediction of simultaneous esophageal lesions in head and neck squamous cell carcinoma: a multivariate analysis.
Chow TL; Lee DT; Choi CY; Chan TT; Lam SH
Arch Otolaryngol Head Neck Surg; 2009 Sep; 135(9):882-5. PubMed ID: 19770420
[TBL] [Abstract][Full Text] [Related]
13. Poor radiotherapy compliance predicts persistent regional disease in advanced head/neck cancer.
Patel UA; Patadia MO; Holloway N; Rosen F
Laryngoscope; 2009 Mar; 119(3):528-33. PubMed ID: 19160390
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus in metastatic squamous carcinoma from unknown primaries in the head and neck: a retrospective 7 year study.
Desai PC; Jaglal MV; Gopal P; Ghim SJ; Miller DM; Farghaly H; Jenson AB
Exp Mol Pathol; 2009 Oct; 87(2):94-8. PubMed ID: 19393644
[TBL] [Abstract][Full Text] [Related]
15. Effect of comorbidity on post-treatment quality of life scores in patients with head and neck squamous cell carcinoma.
Gourin CG; Boyce BJ; Vaught CC; Burkhead LM; Podolsky RH
Laryngoscope; 2009 May; 119(5):907-14. PubMed ID: 19358195
[TBL] [Abstract][Full Text] [Related]
16. Revisiting the role of positron-emission tomography/computed tomography in determining the need for planned neck dissection following chemoradiation for advanced head and neck cancer.
Gourin CG; Boyce BJ; Williams HT; Herdman AV; Bilodeau PA; Coleman TA
Laryngoscope; 2009 Nov; 119(11):2150-5. PubMed ID: 19544378
[TBL] [Abstract][Full Text] [Related]
17. Postoperative reduced dose of cisplatin concomitant with radiation therapy in high- risk head and neck squamous cell carcinoma.
Franchin G; Minatel E; Politi D; Gobitti C; Talamini R; Vaccher E; Savignano MG; Trovo M; Sulfaro S; Barzan L
Cancer; 2009 Jun; 115(11):2464-71. PubMed ID: 19280588
[TBL] [Abstract][Full Text] [Related]
18. Are autopsies useful? Do premorbid findings predict postmortem results in head and neck cancer patients?
Jennings CR; Bradley PJ
Ann R Coll Surg Engl; 2002 Mar; 84(2):133-6. PubMed ID: 11995757
[TBL] [Abstract][Full Text] [Related]
19. Reporting of time-to-event end points and tracking of failures in randomized trials of radiotherapy with or without any concomitant anticancer agent for locally advanced head and neck cancer.
Le Tourneau C; Michiels S; Gan HK; Siu LL
J Clin Oncol; 2009 Dec; 27(35):5965-71. PubMed ID: 19805677
[TBL] [Abstract][Full Text] [Related]
20. Surgical margin determination in head and neck oncology: current clinical practice. The results of an International American Head and Neck Society Member Survey.
Meier JD; Oliver DA; Varvares MA
Head Neck; 2005 Nov; 27(11):952-8. PubMed ID: 16127669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
